SIBNSI-BONE, Inc.
Price
+23%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: safety
Quality strong, a flag to check, growing in the filings, the market with it.
Charts
As reported to the SEC, without any scoring.
SI-BONE, Inc. (SIBN) reported revenue of $56M in Q2 2026 (quarter ended Jun 30, 2026), up 15% from the same quarter a year earlier. That came with a gross margin of 80% and net loss of $4.1M. For the full year FY2025, revenue was $201M (+20% year on year) and net income −$19M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 11, 2026On September 11, 2026, SI-BONE, Inc. (the “Company”) and BIXBY SPE FINANCE 11, LLC (“Landlord”) entered into the Fourth Amendment to Lease (the “Fourth Lease Amendment”) to the Office Lease Agreement dated as of February 2, 2018, as amended by that certain First Amendment to Lease dated as of April 16, 2018, that …Material agreement entered · Form 8-K
- Aug 3, 2026SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance.Earnings release · press release
- Jun 8, 2026On June 5, 2026, SI-BONE, Inc. (the “Company”) and BIXBY SPE FINANCE 11, LLC (“Landlord”) entered into the Third Amendment to Lease (the “Third Lease Amendment”) to the Office Lease Agreement (the “Original Lease”) dated as of February 2, 2018, as amended by that certain First Amendment to Lease (the “First …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
Ranks #38 of 51 by RyuScore